Skip to main content
. 2016 Feb 9;24(4):779–787. doi: 10.1038/mt.2015.235

Figure 5.

Figure 5

Apt 14 inhibits PDGFR-β signaling. Immunoblots of PDGFR-β and PI3K/Akt activation in vascular smooth muscle cell (VSMC) treated in the presence of aptamer (400 nmol/l; 14 or nonselected control (NSC)) following a, PDGF-BB (PDGF; 50 ng/ml). *P < 0.05 versus control. P < 0.05 versus PDGF. Unst = unstimulated. (b) Immunoblots of PDGFR-α and PDGFR-β following pull-down with biotinylated aptamers (200 nmol/l; 14 or NSC) to VSMCs. Input refers to total lysate.